Dr. Jones Nauseef is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. He received his medical degree from University of Iowa Roy J. and Lucille A. Carver College of Medicine and has been in practice 7 years. He is one of 368 doctors at New York-Presbyterian Hospital and one of 368 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 10 publications and over 450 citings.
Scott T Tagawa, Charlene Thomas, A Oliver Sartor, Michael Sun, Judith Stangl-Kremser, Mahelia Bissassar, Shankar Vallabhajosula, Jones T Nauseef, Cora N Sternberg, Ana...> ;Journal of Clinical Oncology. 2024 Mar 1
Ariel E Marciscano, Sydney Wolfe, Xi Kathy Zhou, Christopher E Barbieri, Silvia C Formenti, Jim C Hu, Ana M Molina, David M Nanus, Jones T Nauseef, Douglas S Scherr, C...> ;BMC Cancer. 2023 Aug 22
Judith Stangl-Kremser, Michael Sun, Benedict Ho, Joseph Thomas, Jones T Nauseef, Joseph R Osborne, Ana Molina, Cora N Sternberg, David M Nanus, Neil H Bander, Scott Ta...> ;The Prostate. 2023 Oct 1
Kritika Subramanian, Juana Martinez, Sandra Huicochea Castellanos, Jana Ivanidze, Himanshu Nagar, Sean Nicholson, Trisha Youn, Jones T Nauseef, Scott Tagawa, Joseph R ...> ;Scientific Reports. 2023 May 23
Jose Mauricio Mota, Ethan Barnett, Jones T. Nauseef, Bastien Nguyen, Konrad H. Stopsack, Andreas Wibmer, Jessica Flynn, Glenn Heller, Daniel C. Danila, Dana E. Rathkop...> ;JCO Precision Oncology. 2020 Apr 16
Jones T. Nauseef, Dario Martin Villamar, Justin M Lebenthal, Panagiotis J. Vlachostergios, Scott T. Tagawa> ;Expert Opinion on Pharmacotherapy. 2020 Mar 3
Robust PSA Drops with Radionuclide Therapy in Castration-Resistant Prostate CancerApril 18th, 2023
ASCO GU 2021: Prevalence of Microsatellite Instability and Monitoring Response to Immune Checkpoint Inhibition Utilizing Liquid Biopsy Among African American Men with Advanced Prostate CancerFebruary 12th, 2021
ASCO GU 2021: Multi-Institutional Evaluation of the Clinical Outcomes and Genomic Correlates of African Americans with Metastatic Castration-Sensitive Prostate CancerFebruary 11th, 2021